U.S., Oct. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07903987) titled 'Assessment of the Value of FAPI and FDG-PET-CT in Diagnosis of Acute Phase Peyronie's Disease' on Oct. 12.
Brief Summary: The goal of this clinical trial is to learn if FAPI-PET/CT and/or FDG-PET/CT scan is able to detect active fibroblast tissue and inflammation in patients with acute or chronic phase PD.
* Does FAPI PET/CT scan or FDG PET/CT scan show any uptake of inflammatory tissue in patients with Peyronie's disease
* Participants will undergo a FAPI PET/CT scan and FDG PET/CT scan after diagnosis of Peyronie's disease.
Study Start Date: Dec. 13, 2024
Study Type: INTERVENTIONAL
Condition:
Peyronie's Disease
Intervention...